{
    "organizations": [],
    "uuid": "0b5882ea11e7fc53ca890a89a75d8e5ac30bd981",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amgen-expects-to-launch-migraine-d/brief-amgen-expects-to-launch-migraine-drug-this-year-idUSL1N1P40YG",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Expects To Launch Migraine Drug This Year",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 5:00 PM / Updated 15 minutes ago BRIEF-Amgen Expects To Launch Migraine Drug This Year Reuters Staff \nJan 9 (Reuters) - Amgen Inc: \n* AMGEN CEO SAYS EXPECTS TO BE ABLE TO LAUNCH AIMOVIG FOR MIGRAINE THIS YEAR \n* AMGEN SAYS EXPECTS TO LAUNCH HUMIRA BIOSIMILAR OUTSIDE U.S. THIS YEAR \n* AMGEN CEO SAYS BUSINESS DEVELOPMENT DEALS TO REMAIN PRIORITY IN 2018 \n* AMGEN CEO SAYS COMPANY IN STRONGER STRATEGIC POSITION AFTER TAX REFORM Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)",
    "published": "2018-01-09T18:59:00.000+02:00",
    "crawled": "2018-01-09T19:18:18.052+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "expects",
        "launch",
        "migraine",
        "drug",
        "year",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "ceo",
        "say",
        "expects",
        "able",
        "launch",
        "aimovig",
        "migraine",
        "year",
        "amgen",
        "say",
        "expects",
        "launch",
        "humira",
        "biosimilar",
        "outside",
        "year",
        "amgen",
        "ceo",
        "say",
        "business",
        "development",
        "deal",
        "remain",
        "priority",
        "amgen",
        "ceo",
        "say",
        "company",
        "stronger",
        "strategic",
        "position",
        "tax",
        "reform",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "bill",
        "berkrot"
    ]
}